Primary aldosteronism is woefully underdiagnosed as a cause of hypertension and end-organ damage. In a recent Review published in AJKD, Mario Funes Hernandez and Vivek Bhalla discuss the prevalence of primary aldosteronism as well as a number of issues related to screening, in an effort to encourage higher rates of screening and diagnosis of this common, consequential, and treatable disease.

AJKDBlog’s Interviews Editor Timothy Yau @Maximal_Change sat down with Drs Hernandez @MarioFunesMD and Bhalla @BhallaResearch for a deeper dive.

If the embedded player above doesn’t work, please click here to watch the video interview. Special thanks to Drs Hernandez and Bhalla for agreeing to do the interview!

Diagnostic algorithm for primary aldosteronism. Figure 1 from Hernandez and Bhalla, AJKD © National Kidney Foundation.

To view this Review (Freely Available), please visit AJKD.org

Title: Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection
Author: Mario Funes Hernandez and Vivek Bhalla
DOI: 10.1053/j.ajkd.2023.01.447

Review articles cover clinical, translational, or basic science topics of interest to practitioners. Reviews published in the last two years are freely available.